| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 161.69B | 162.01B | 177.97B | 191.28B | 168.34B |
| Gross Profit | 45.55B | 42.49B | 51.34B | 54.79B | 50.88B |
| EBITDA | 25.63B | 22.60B | 30.39B | 34.43B | 34.91B |
| Net Income | -10.69B | 7.80B | 9.73B | 16.87B | 14.16B |
Balance Sheet | |||||
| Total Assets | 338.44B | 345.30B | 328.51B | 296.40B | 282.64B |
| Cash, Cash Equivalents and Short-Term Investments | 29.73B | 21.50B | 23.13B | 32.20B | 30.64B |
| Total Debt | 119.66B | 84.71B | 53.59B | 24.99B | 27.49B |
| Total Liabilities | 171.26B | 134.16B | 107.48B | 79.63B | 81.91B |
| Stockholders Equity | 165.23B | 209.37B | 219.26B | 215.20B | 199.22B |
Cash Flow | |||||
| Free Cash Flow | 4.75B | -14.31B | -21.10B | 8.51B | 15.99B |
| Operating Cash Flow | 28.01B | 29.52B | 11.60B | 22.74B | 28.58B |
| Investing Cash Flow | -13.72B | -39.44B | -34.29B | -11.10B | -11.00B |
| Financing Cash Flow | -7.96B | 8.44B | 12.13B | -10.48B | -6.11B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥182.70B | 18.42 | ― | 2.84% | 4.10% | 5.25% | |
74 Outperform | ¥549.18B | 22.24 | 6.52% | 1.82% | 4.95% | 52.94% | |
73 Outperform | ¥321.38B | 10.92 | 5.47% | 3.41% | 0.55% | 25.37% | |
73 Outperform | ¥414.03B | 11.56 | 9.59% | 3.91% | -2.06% | 46.42% | |
72 Outperform | ¥2.01T | 15.07 | 11.98% | 1.54% | 1.41% | 0.76% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
46 Neutral | ¥148.65B | -14.73 | 4.24% | 3.76% | -0.20% | -276.01% |